Related Experiment Videos

[Clinical utility of Gd-DTPA subtraction MR imaging for spinal bone metastasis]

K Ando1, M Murakami, Y Kuroda

  • 1Department of Radiology, Tenri Hospital.

Insights

Gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA) enhanced MRI improves spinal bone metastasis detection. Subtraction imaging offers a valuable diagnostic tool for assessing bone metastases.

Area of Science:

  • Radiology
  • Oncology
  • Medical Imaging

Context:

  • Spinal bone metastases present diagnostic challenges.
  • Gadolinium-based contrast agents (Gd-DTPA) are used in MRI for tumor detection.
  • Evaluating the efficacy of Gd-DTPA in spinal bone metastasis imaging is crucial.

Purpose:

  • To assess the utility of Gd-DTPA enhanced MRI, specifically subtraction imaging, for detecting spinal bone metastases.
  • To compare the detectability of metastases using original T1WI and subtracted Gd-DTPA T1WI.
  • To characterize Gd-DTPA perfusion patterns in the spinal region.

Summary:

  • Gd-DTPA was administered to 31 patients with 97 spinal bone metastases.
  • Gd-DTPA increased tumor and bone marrow signal intensity in 53% of cases.
  • Subtraction imaging (Gd-DTPA T1WI minus original T1WI) improved detectability to 96%, though slightly lower than original T1WI (99%).
  • Gd-DTPA perfusion was highest in paravertebral veins and lowest in spinal cord and bone cortex.

Impact:

  • Gd-DTPA enhanced subtraction MRI serves as a novel diagnostic tool for spinal bone metastasis.
  • This technique aids in the detection and assessment of bone metastases.
  • Understanding normal Gd-DTPA perfusion patterns is essential for accurate diagnosis.

Related Concept Videos